Cavanaugh Sarah
- SEC CIK
- 0001709113
No open-market purchases or sales filed in the past year.
Current role at each company
- CLDX Celldex Therapeutics, Inc.SVP OF CORP AFFAIRS & ADMIN.as of Jun 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cavanaugh Sarah as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 (view filing) | May 30 | 4 days | Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN. | SSale | −20.9K | $33.73 | −$703.4K | −91.8%1.86K after | |
| Aug 19, 2022 (view filing) | Aug 17-18 | 2 days | Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN. | SSale | −32.7K | $36.72 | −$1.20M | −96.2%1.28K after | 2 lots |
| Dec 10, 2021 (view filing) | Dec 8 | 2 days | Cavanaugh SarahSVP of Corp Affairs & Admin. | SSale | −7.32K | $40.00 | −$292.9K | −94.7%408 after | |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Cavanaugh SarahSVP of Corp Affairs & Admin. | SSale | −7.32K | $43.26 | −$316.8K | −94.7%408 after | 3 lots |